Rox’s Definitive Feasibility Study (DFS) will be the most comprehensive technical and financial assessment of the Youanmi Gold Project.It is a major de-risking milestone and the foundation upon which project financing will be secured.Rox will be presenting at the Australian Gold Conference—Oct 13 – 15th.The Australian Gold Conference is unlike a typical mining conference; it is the only event in Australia specifically designed to bring the entire precious metals industry together under one roof to meet with the investment community.Perfect for a company with a strong DFS seeking finance to construct its mine.The MRE, Mine Plan, Approvals, DFS, Reserve and Albion Test work results will be announced in the next few months.Before the end of the year, Rox will likely get funding for mine construction.Mine construction contracts will be in place before the end of this year or in January Y26.Rox is moving along its development path at a blistering pace that is unmatched by its peers,CEO Phill Wilding’s approach is that at the end of the day, it’s shareholders who are funding these developments and the company’s job is to deliver returns.The share price is not reflecting the progress, and that is suiting instos very well as they accumulate.@Meg25: Agree with your analysis. A long consolidation within narrow Bollinger Bands will end with an explosive high-volume re-rate of the share price.
- Forums
- ASX - By Stock
- RXL
- Ann: On the Path to Development
RXL
rox resources limited
Add to My Watchlist
1.75%
!
29.0¢

Ann: On the Path to Development, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $212.4M |
Open | High | Low | Value | Volume |
28.5¢ | 29.5¢ | 28.5¢ | $783.8K | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 87999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.285 |
1 | 85506 | 0.280 |
2 | 52000 | 0.275 |
12 | 315190 | 0.270 |
3 | 243500 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 27999 | 1 |
0.295 | 106291 | 2 |
0.300 | 128300 | 4 |
0.305 | 144436 | 3 |
0.310 | 60003 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online